|
1.
|
Tao M, Ma D, Li Y, Zhou C, Zhang Y, Duan
W, Xu X, Wang R, Wu L and Liu H: Clinical significance of
circulating tumor cells in breast cancer patients. Breast Cancer
Res Treat. 129:247–254. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Swaby RF and Cristofanilli M: Circulating
tumor cells in breast cancer: a tool whose time has come of age.
BMC Med. 9:432011. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Honn KV, Tang DG and Crissman JD:
Platelets and cancer metastasis: a causal relationship? Cancer
Metastasis Rev. 11:325–351. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Sørensen HT, Mellemkjaer L, Steffensen FH,
Olsen JH and Nielsen GL: The risk of a diagnosis of cancer after
primary deep venous thrombosis or pulmonary embolism. N Engl J Med.
338:1169–1173. 1998.
|
|
5.
|
Bazou D, Santos-Martinez MJ, Medina C and
Radomski MW: Elucidation of flow-mediated tumour cell-induced
platelet aggregation using an ultrasound standing wave trap. Br J
Pharmacol. 162:1577–1589. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Gasic GJ, Gasic TB and Stewart CC:
Antimetastatic effects associated with platelet reduction. Proc
Natl Acad Sci USA. 61:46–52. 1968. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Gasic GJ, Gasic TB, Galanti N, Johnson T
and Murphy S: Platelet-tumor-cell interactions in mice. The role of
platelets in the spread of malignant disease. Int J Cancer.
11:704–718. 1973. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Philippe C, Philippe B, Fouqueray B, Perez
J, Lebret M and Baud L: Protection from tumor necrosis
factor-mediated cytolysis by platelets. Am J Pathol. 143:1713–1723.
1993.PubMed/NCBI
|
|
9.
|
Malik AB: Pulmonary microembolism. Physiol
Rev. 63:1114–1207. 1983.PubMed/NCBI
|
|
10.
|
Mehta P: Potential role of platelets in
the pathogenesis of tumor metastasis. Blood. 63:55–63.
1984.PubMed/NCBI
|
|
11.
|
Honn KV, Tang DG and Chen YQ: Platelets
and cancer metastasis: more than an epiphenomenon. Semin Thromb
Hemost. 18:392–415. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Verheul HM, Hoekman K, Lupu F, Broxterman
HJ, van der Valk P, Kakkar AK and Pinedo HM: Platelet and
coagulation activation with vascular endothelial growth factor
generation in soft tissue sarcomas. Clin Cancer Res. 6:166–171.
2000.PubMed/NCBI
|
|
13.
|
Katagiri Y, Hayashi Y, Baba I, Suzuki H,
Tanoue K and Yamazaki H: Characterization of platelet aggregation
induced by the human melanoma cell line HMV-I: roles of heparin,
plasma adhesive proteins, and tumor cell membrane proteins. Cancer
Res. 51:1286–1293. 1991.PubMed/NCBI
|
|
14.
|
Tohgo A, Tanaka NG and Ogawa H:
Platelet-aggregating activities of metastasizing tumor cells. III
Platelet aggregation as resulting from thrombin generation by tumor
cells. Invasion Metastasis. 5:96–105. 1985.PubMed/NCBI
|
|
15.
|
Ugen KE, Mahalingam M, Klein PA and Kao
KJ: Inhibition of tumor cell-induced platelet aggregation and
experimental tumor metastasis by the synthetic Gly-Arg-Gly-Asp-Ser
peptide. J Natl Cancer Inst. 80:1461–1466. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Nash GF, Turner LF, Scully MF and Kakkar
AK: Platelets and cancer. Lancet Oncol. 3:425–430. 2002. View Article : Google Scholar
|
|
17.
|
Du X, Beutler L, Ruan C, Castaldi PA and
Berndt MC: Glycoprotein Ib and glycoprotein IX are fully complexed
in the intact platelet membrane. Blood. 69:1524–1527.
1987.PubMed/NCBI
|
|
18.
|
Zhang G, Han J, Welch EJ, Ye RD,
Voyno-Yasenetskaya TA, Malik AB, Du X and Li Z: Lipopolysaccharide
stimulates platelet secretion and potentiates platelet aggregation
via TLR4/MyD88 and the cGMP-dependent protein kinase pathway. J
Immunol. 182:7997–8004. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Sakai H, Suzuki T, Murota M, Takahashi Y
and Takeguchi N: Nitric oxide-induced Cl- secretion in isolated rat
colon is mediated by the release of thromboxane A2. J Physiol.
543(Pt 1): 261–271. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Chung AW, Jurasz P, Hollenberg MD and
Radomski MW: Mechanisms of action of proteinase-activated receptor
agonists on human platelets. Br J Pharmacol. 135:1123–1132. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Tsuruo T and Fujita N: Platelet
aggregation in the formation of tumor metastasis. Proc Jpn Acad Ser
B Phys Biol Sci. 84:189–198. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Egan K, Crowley D, Smyth P, O’Toole S,
Spillane C, Martin C, Gallagher M, Canney A, Norris L, Conlon N, et
al: Platelet adhesion and degranulation induce pro-survival and
pro-angiogenic signalling in ovarian cancer cells. PloS One.
6:e261252011. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Swaim MW, Chiang HS and Huang TF:
Characterisation of platelet aggregation induced by PC-3 human
prostate adenocarcinoma cells and inhibited by venom peptides,
trigramin and rhodostomin. Eur J Cancer. 32A:715–721. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Camerer E, Qazi AA, Duong DN, Cornelissen
I, Advincula R and Coughlin SR: Platelets, protease-activated
receptors, and fibrinogen in hematogenous metastasis. Blood.
104:397–401. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Jain S, Zuka M, Liu J, Russell S, Dent J,
Guerrero JA, Forsyth J, Maruszak B, Gartner TK, Felding-Habermann B
and Ware J: Platelet glycoprotein Ib alpha supports experimental
lung metastasis. Proc Natl Acad Sci USA. 104:9024–9028. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Honn KV: Inhibition of tumor cell
metastasis by modulation of the vascular prostacyclin/thromboxane
A2 system. Clin Exp Metastasis. 1:103–114. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Zacharski LR, Henderson WG, Rickles FR,
Forman WB, Cornell CJ Jr, Forcier RJ, Harrower HW and Johnson RO:
Rationale and experimental design for the VA Cooperative Study of
Anticoagulation (Warfarin) in the Treatment of Cancer. Cancer.
44:732–741. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Santos-Martinez MJ, Medina C, Jurasz P and
Radomski MW: Role of metalloproteinases in platelet function.
Thromb Res. 121:535–542. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Andrews RK and Berndt MC: Platelet
physiology and thrombosis. Thromb Res. 114:447–453. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Shattil SJ, Kashiwagi H and Pampori N:
Integrin signaling: the platelet paradigm. Blood. 91:2645–2657.
1998.PubMed/NCBI
|
|
31.
|
Amirkhosravi A, Mousa SA, Amaya M, Blaydes
S, Desai H, Meyer T and Francis JL: Inhibition of tumor
cell-induced platelet aggregation and lung metastasis by the oral
GPIIb/IIIa antagonist XV454. Thromb Haemost. 90:549–554.
2003.PubMed/NCBI
|
|
32.
|
Trikha M, Zhou Z, Timar J, Raso E, Kennel
M, Emmell E and Nakada MT: Multiple roles for platelet GPIIb/IIIa
and alphavbeta3 integrins in tumor growth, angiogenesis, and
metastasis. Cancer Res. 62:2824–2833. 2002.PubMed/NCBI
|
|
33.
|
Bakewell SJ, Nestor P, Prasad S, Tomasson
MH, et al: Platelet and osteoclast beta3 integrins are critical for
bone metastasis. Proc Natl Acad Sci USA. 100:14205–14210. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
de Leval X, Benoit V, Delarge J, Julémont
F, Masereel B, Pirotte B, Merville MP, David JL and Dogné JM:
Pharmacological evaluation of the novel thromboxane modulator
BM-567 (II/II). Effects of BM-567 on osteogenic
sarcoma-cell-induced platelet aggregation. Prostaglandins Leukot
Essent Fatty Acids. 68:55–59. 2003.PubMed/NCBI
|
|
35.
|
Boukerche H, Berthier-Vergnes O, Penin F,
Tabone E, Lizard G, Bailly M and McGregor JL: Human melanoma cell
lines differ in their capacity to release ADP and aggregate
platelets. Br J Haematol. 87:763–772. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Bastida E, Escolar G, Almirall L and
Ordinas A: Platelet activation induced by a human neuroblastoma
tumor cell line is reduced by prior administration of ticlopidine.
Thromb Haemost. 55:333–337. 1986.PubMed/NCBI
|
|
37.
|
Dogné JM, de Leval X, Delarge J, David JL
and Masereel B: New trends in thromboxane and prostacyclin
modulators. Curr Med Chem. 7:609–628. 2000.
|
|
38.
|
Ogletree ML: Overview of physiological and
pathophysiological effects of thromboxane A2. Fed Proc. 46:133–138.
1987.PubMed/NCBI
|
|
39.
|
Nie D, Lamberti M, Zacharek A, Li L,
Szekeres K, Tang K, Chen Y and Honn KV: Thromboxane A(2) regulation
of endothelial cell migration, angiogenesis, and tumor metastasis.
Biochem Biophys Res Commun. 267:245–251. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
40.
|
Yokoyama I, Hayashi S, Kobayashi T, Negita
M, Yasutomi M, Uchida K and Takagi H: Prevention of experimental
hepatic metastasis with thromboxane synthase inhibitor. Res Exp Med
(Berl). 195:209–215. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
41.
|
Medina C, Jurasz P, Santos-Martinez MJ,
Jeong SS, Mitsky T, Chen R and Radomski MW: Platelet
aggregation-induced by caco-2 cells: regulation by matrix
metalloproteinase-2 and adenosine diphosphate. J Pharmacol Exp
Ther. 317:739–745. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
42.
|
Jurasz P, Sawicki G, Duszyk M, Sawicka J,
Miranda C, Mayers I and Radomski MW: Matrix metalloproteinase 2 in
tumor cell-induced platelet aggregation: regulation by nitric
oxide. Cancer Res. 61:376–382. 2001.PubMed/NCBI
|
|
43.
|
Alonso-Escolano D, Strongin AY, Chung AW,
Deryugina EI and Radomski MW: Membrane type-1 matrix
metalloproteinase stimulates tumour cell-induced platelet
aggregation: role of receptor glycoproteins. Br J Pharmacol.
141:241–252. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
44.
|
Bambace NM, Levis JE and Holmes CE: The
effect of P2Y-mediated platelet activation on the release of VEGF
and endostatin from platelets. Platelets. 21:85–93. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
45.
|
Uluckan O, Eagleton MC, Floyd DH, Morgan
EA, et al: APT102, a novel adpase, cooperates with aspirin to
disrupt bone metastasis in mice. J Cell Biochem. 104:1311–1323.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
46.
|
Choe KS, Correa D, Jani AB and Liauw SL:
The use of anticoagulants improves biochemical control of localized
prostate cancer treated with radiotherapy. Cancer. 116:1820–1826.
2010. View Article : Google Scholar : PubMed/NCBI
|
